Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Viela Bio Inc (VIE)

Viela Bio Inc (VIE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,981,744
  • Shares Outstanding, K 50,997
  • Annual Sales, $ 50,000 K
  • Annual Income, $ -86,430 K
  • 60-Month Beta N/A
  • Price/Sales 43.24
  • Price/Cash Flow N/A
  • Price/Book 6.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -1.03
  • Number of Estimates 4
  • High Estimate -0.82
  • Low Estimate -1.20
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.20 +1.73%
on 07/10/20
55.18 -29.58%
on 06/12/20
-13.10 (-25.21%)
since 06/10/20
3-Month
30.80 +26.17%
on 04/13/20
65.00 -40.22%
on 05/20/20
+6.24 (+19.13%)
since 04/09/20

Most Recent Stories

More News
Electric Vehicle Battery Recycling Market- Growth Insight, Emerging Trends, Rising Demand & Revenue Growth by the end of 2027

The statistics portray the rising costs of highly valuable metals, which is raising the manufacturing costs of electric vehicle batteries (EVBs). EVBs are manufactured by using several elements, which...

AMY.VN : 0.190 (unch)
VIE : 38.86 (-8.33%)
SRG : 10.19 (+3.45%)
Viela Bio Announces Pricing of Public Offering of Common Stock

Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the pricing of an underwritten public offering...

MS : 49.80 (+4.82%)
VIE : 38.86 (-8.33%)
Viela Bio Announces Proposed Public Offering of Common Stock

Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced that it intends to offer and sell, subject to...

MS : 49.80 (+4.82%)
VIE : 38.86 (-8.33%)
The Zacks Analyst Blog Highlights: LOGI, GO, GFL, HCAT and VIE

The Zacks Analyst Blog Highlights: LOGI, GO, GFL, HCAT and VIE

LOGI : 67.03 (-0.67%)
GO : 41.61 (-3.10%)
VIE : 38.86 (-8.33%)
GFL : 18.80 (+0.70%)
HCAT : 33.95 (+4.75%)
6 Top Stocks to Buy Ahead of Earnings Results This Week

Despite the negative earnings trend, a handful of stocks with a favorable Zacks Rank are poised to beat earnings estimates this week.

LOGI : 67.03 (-0.67%)
GO : 41.61 (-3.10%)
SSRM : 22.47 (-1.38%)
VIE : 38.86 (-8.33%)
GFL : 18.80 (+0.70%)
HCAT : 33.95 (+4.75%)
Why Viela Bio (VIE) Might Surprise This Earnings Season

Viela Bio (VIE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

VIE : 38.86 (-8.33%)
Packaged Wastewater Treatment Market Size 2020-2025, Industry Share, Growth, Price Trends, Analysis, Outlook and Forecast

According to a new report by Expert Market Research titled, '', the attained a value of nearly USD 17.56 billion in 2019. It is further expected to grow at a CAGR of 10.4% between 2020 and 2025 to attain...

CLI.VN : 0.015 (unch)
CLI : 14.48 (+1.40%)
SEV : 21.97 (-0.14%)
VIE : 38.86 (-8.33%)
FLC : 20.43 (-0.34%)
Why Earnings Season Could Be Great for Viela Bio (VIE)

Viela Bio (VIE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season

VIE : 38.86 (-8.33%)
Viela Bio Reaches Analyst Target Price

In recent trading, shares of Viela Bio Inc have crossed above the average analyst 12-month target price of $46.33, changing hands for $52.88/share. When a stock reaches the target an analyst has set,...

VIE : 38.86 (-8.33%)
Is a Surprise Coming for Viela Bio (VIE) This Earnings Season?

Viela Bio (VIE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

VIE : 38.86 (-8.33%)
Trade VIE with:

Business Summary

Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

2nd Resistance Point 43.71
1st Resistance Point 41.29
Last Price 38.86
1st Support Level 37.32
2nd Support Level 35.77

See More

52-Week High 70.66
Fibonacci 61.8% 50.62
Fibonacci 50% 44.43
Last Price 38.86
Fibonacci 38.2% 38.24
52-Week Low 18.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar